Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
AMG 319 Lymphoid Malignancy FIH
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998
- Status
- UNKNOWN
- Phase
- N/A
Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Empirical Versus Preemptive Antifungal Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)
- Status
- COMPLETED
- Phase
- N/A
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
- Status
- TERMINATED
- Phase
- PHASE2
Phase l/II Study of Ruxolitinib for Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A